Dmitry Kashirskikh

557 total citations · 1 hit paper
17 papers, 393 citations indexed

About

Dmitry Kashirskikh is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Dmitry Kashirskikh has authored 17 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Dmitry Kashirskikh's work include Atherosclerosis and Cardiovascular Diseases (10 papers), Glycosylation and Glycoproteins Research (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Dmitry Kashirskikh is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (10 papers), Glycosylation and Glycoproteins Research (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Dmitry Kashirskikh collaborates with scholars based in Russia, Taiwan and Italy. Dmitry Kashirskikh's co-authors include Alexander N. Orekhov, Anastasia V. Poznyak, Veronika A. Myasoedova, Е. В. Герасимова, Alexander M. Markin, Nikita G. Nikiforov, Victoria A. Khotina, Andrey V. Grechko, Dimitry A. Chistiakov and Mirza S. Baig and has published in prestigious journals such as International Journal of Molecular Sciences, Atherosclerosis and Current Medicinal Chemistry.

In The Last Decade

Dmitry Kashirskikh

15 papers receiving 387 citations

Hit Papers

Overview of OxLDL and Its... 2021 2026 2022 2024 2021 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis
    2021 250 citations Anastasia V. Poznyak, Nikita G. Nikiforov et al. Frontiers in Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dmitry Kashirskikh Russia 6 161 122 81 74 55 17 393
Е. В. Герасимова Russia 9 186 1.2× 181 1.5× 85 1.0× 64 0.9× 72 1.3× 53 536
Paola Caielli Italy 8 85 0.5× 116 1.0× 47 0.6× 65 0.9× 62 1.1× 9 369
Marta Riera-Borrull Spain 12 137 0.9× 234 1.9× 143 1.8× 50 0.7× 21 0.4× 17 556
Alexis Stamatikos United States 14 70 0.4× 186 1.5× 57 0.7× 141 1.9× 36 0.7× 33 488
Yilan Shen China 10 51 0.3× 212 1.7× 60 0.7× 42 0.6× 30 0.5× 20 453
Xueling Liao China 10 84 0.5× 128 1.0× 35 0.4× 57 0.8× 22 0.4× 14 321
Dawei Lian China 11 65 0.4× 214 1.8× 47 0.6× 58 0.8× 21 0.4× 25 370
Hayato Urushima Japan 10 63 0.4× 129 1.1× 36 0.4× 44 0.6× 27 0.5× 19 389
Marcela Aparicio-Vergara Netherlands 9 74 0.5× 121 1.0× 186 2.3× 48 0.6× 27 0.5× 11 372

Countries citing papers authored by Dmitry Kashirskikh

Since Specialization
Citations

This map shows the geographic impact of Dmitry Kashirskikh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitry Kashirskikh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitry Kashirskikh more than expected).

Fields of papers citing papers by Dmitry Kashirskikh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dmitry Kashirskikh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitry Kashirskikh. The network helps show where Dmitry Kashirskikh may publish in the future.

Co-authorship network of co-authors of Dmitry Kashirskikh

This figure shows the co-authorship network connecting the top 25 collaborators of Dmitry Kashirskikh. A scholar is included among the top collaborators of Dmitry Kashirskikh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dmitry Kashirskikh. Dmitry Kashirskikh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Khotina, Victoria A., et al.. (2025). Incretin-Based Therapies Through the Decades: Molecular Innovations and Clinical Impact. Medical Sciences. 13(4). 269–269.
3.
4.
Khotina, Victoria A., et al.. (2025). Antimicrobial Peptides of the Cathelicidin Family: Focus on LL-37 and Its Modifications. International Journal of Molecular Sciences. 26(16). 8103–8103. 1 indexed citations
5.
Kashirskikh, Dmitry, et al.. (2024). Mouse Model of Low-density Lipoprotein Desialylation In Vivo. Current Medicinal Chemistry. 33(8). 1523–1537. 1 indexed citations
6.
Kashirskikh, Dmitry, et al.. (2023). A novel insight into the nature of modified low-density lipoproteins and their role in atherosclerosis. Vessel Plus. 7. 3–3. 3 indexed citations
7.
Poznyak, Anastasia V., et al.. (2023). Sialic acid as the potential link between lipid metabolism and inflammation in the pathogenesis of atherosclerosis. Brazilian Journal of Medical and Biological Research. 56. e12972–e12972. 5 indexed citations
8.
Kashirskikh, Dmitry, et al.. (2023). Effect of LDL desialylation on the development of atherosclerosis in mice. Atherosclerosis. 379. S73–S73. 1 indexed citations
9.
Poznyak, Anastasia V., et al.. (2022). Cholesterol Transport Dysfunction and Its Involvement in Atherogenesis. International Journal of Molecular Sciences. 23(3). 1332–1332. 25 indexed citations
10.
Poznyak, Anastasia V., Nikita G. Nikiforov, Alexander M. Markin, et al.. (2021). Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis. Frontiers in Pharmacology. 11. 613780–613780. 250 indexed citations breakdown →
11.
Mezentsev, Alexandre, Evgeny E. Bezsonov, Dmitry Kashirskikh, et al.. (2021). Proatherogenic Sialidases and Desialylated Lipoproteins: 35 Years of Research and Current State from Bench to Bedside. Biomedicines. 9(6). 600–600. 34 indexed citations
12.
Kashirskikh, Dmitry, et al.. (2020). Sialidase Activity in Human Blood Serum Has a Distinct Seasonal Pattern: A Pilot Study. Biology. 9(8). 184–184. 5 indexed citations
13.
14.
Kashirskikh, Dmitry, Victoria A. Khotina, Vasily N. Sukhorukov, Igor A. Sobenin, & Alexander N. Orekhov. (2020). Cell and tissue markers of atherosclerosis. Complex Issues of Cardiovascular Diseases. 9(2). 102–113. 1 indexed citations
15.
Kashirskikh, Dmitry, Alexander M. Markin, Igor A. Sobenin, & Alexander N. Orekhov. (2020). Study of the role of human endogenous neuraminidases in atherosclerotic lesions of the thoracic aorta. Atherosclerosis. 315. e114–e115.
16.
Khotina, Victoria A., Vasily N. Sukhorukov, Dmitry Kashirskikh, Igor A. Sobenin, & Alexander N. Orekhov. (2020). Cholesterol metabolism in macrophages. Complex Issues of Cardiovascular Diseases. 9(2). 91–101. 5 indexed citations
17.
Chistiakov, Dimitry A., Dmitry Kashirskikh, Victoria A. Khotina, Andrey V. Grechko, & Alexander N. Orekhov. (2019). Immune-Inflammatory Responses in Atherosclerosis: The Role of Myeloid Cells. Journal of Clinical Medicine. 8(11). 1798–1798. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Е. В. Герасимова Breakdown of academic impact, for papers by Paola Caielli Breakdown of academic impact, for papers by Marta Riera-Borrull Breakdown of academic impact, for papers by Alexis Stamatikos Breakdown of academic impact, for papers by Yilan Shen Breakdown of academic impact, for papers by Xueling Liao Breakdown of academic impact, for papers by Dawei Lian Breakdown of academic impact, for papers by Hayato Urushima Breakdown of academic impact, for papers by Marcela Aparicio-Vergara
Rankless by CCL
2026